approval
saveSUBLOCADE (BUPRENORPHINE) — FDA approval
community read0 votes
Sponsor: INDIVIOR. Form: SOLUTION, EXTENDED RELEASE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalBRIXADI (BUPRENORPHINE) — FDA approvalDec 22, 2025 · 284d ago
- approvalSUBLOCADE (BUPRENORPHINE) — FDA approvalDec 22, 2025 · 284d ago
- approvalBRIXADI (BUPRENORPHINE) — FDA approvalAug 29, 2025 · 399d ago
- approvalSUBLOCADE (BUPRENORPHINE) — FDA approvalApr 11, 2025 · 539d ago
- approvalBRIXADI (BUPRENORPHINE) — FDA approvalMar 28, 2025 · 553d ago
- approvalSUBLOCADE (BUPRENORPHINE) — FDA approvalFeb 21, 2025 · 588d ago
- approvalSUBLOCADE (BUPRENORPHINE) — FDA approvalApr 19, 2024 · 896d ago
- approvalSUBLOCADE (BUPRENORPHINE) — FDA approvalDec 15, 2023 · 1022d ago
same company · ±60 days · 3
- approvalBUPRENORPHINE HYDROCHLORIDE: SUBOXONE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalJun 17, 2022
- approvalBUPRENORPHINE HYDROCHLORIDE: SUBOXONE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalJun 17, 2022
- approvalBUPRENORPHINE HYDROCHLORIDE: SUBOXONE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalMay 3, 2022
comments(0)
5-min edit window · permanent after that